Mice with Col1a1-dependent Ccn2 ablation bearing B16F10 tumors showed impaired expression of canonical CAF markers including aSMA with reduced tumor angiogenesis (Hutchenreuther et al., 2018). The gene discussed is COL1A1; the disease is neoplasm.